Ion channel drug discovery and modern medicine

Rogers, M. MedNous, November-December 2019. Article published in the November-December 2019 edition of ‘MedNous’, a publication of Evernow Publishing Ltd.

View

Recommended Publications

Latest Publications

Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806

NS5806, widely used as a Kv4-selective activator, also activates TREK-1 and TREK-2 potassium channels.

Beyond Hybridisation: Biologically Meaningful Protein Interactions of Oligonucleotides

Nature Communications paper ‘The nucleobase guanine at the 3′-terminus of oligonucleotide RGLS4326 drives off-target AMPAR inhibition and CNS toxicity'

View All

Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806

Future-proof cardiac safety: Scalable hiPSC cardiomyocyte new approach methodologies (NAMs) that de-risk earlier and strengthen IND packages

View All